Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.
作者信息
Schneider Lon S
机构信息
Department of Psychiatry and Behavioral Sciences and Department of Neurology, Keck School of Medicine, and Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
出版信息
Alzheimers Dement. 2009 Mar;5(2):172-9. doi: 10.1016/j.jalz.2009.01.023.
PMID:19328454
Abstract
摘要
相似文献
1
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.
Alzheimers Dement. 2009 Mar;5(2):172-9. doi: 10.1016/j.jalz.2009.01.023.
2
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
Alzheimers Dement. 2009 Mar;5(2):147-8. doi: 10.1016/j.jalz.2009.01.007.
3
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
Alzheimers Dement. 2009 Mar;5(2):130-2. doi: 10.1016/j.jalz.2009.01.014.
4
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad.
Alzheimers Dement. 2009 Mar;5(2):157-8. doi: 10.1016/j.jalz.2009.01.009.
5
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.
Alzheimers Dement. 2009 Mar;5(2):149-53. doi: 10.1016/j.jalz.2009.01.012.
6
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
Alzheimers Dement. 2009 Mar;5(2):133-6. doi: 10.1016/j.jalz.2009.01.006.
7
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.
Alzheimers Dement. 2009 Mar;5(2):108-13. doi: 10.1016/j.jalz.2009.01.015.
8
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import.
Alzheimers Dement. 2009 Mar;5(2):154-6. doi: 10.1016/j.jalz.2009.01.011.
9
Commentary on "a roadmap for the prevention of dementia: the inaugural Leon Thal Symposium." An impending prevention clinical trial for Alzheimer's disease: roadmaps and realities.
Alzheimers Dement. 2008 May;4(3):164-6. doi: 10.1016/j.jalz.2008.03.007.
10
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.
Alzheimers Dement. 2009 Mar;5(2):140-2. doi: 10.1016/j.jalz.2009.01.004.
Zotero 插件